BioSpace News Archive

Business

Edwards Lifesciences to Host Earnings Conference Call on October 24, 2024

October 17, 2024
·
1 min read
Press Releases

The Michael J. Fox Foundation Launches Initiative to Expedite Development of LRRK2-targeted Therapies and Biomarkers for Parkinson’s Disease

October 17, 2024
·
5 min read
News

Marinus Pharmaceuticals Presents Clinical Data From Pivotal Phase 3 RAISE Trial in Refractory Status Epilepticus at the Neurocritical Care Society 2024 Annual Meeting

October 17, 2024
·
7 min read
Press Releases

Palvella Therapeutics Appoints Matthew E. Korenberg as Chief Financial Officer

October 17, 2024
·
7 min read
Press Releases

Intra-Cellular Therapies to Host Third Quarter 2024 Financial Results Conference Call and Webcast

October 17, 2024
·
1 min read
Press Releases

Rani Therapeutics Announces New Preclinical Pharmacokinetic Data Supporting Transenteric Delivery of GLP-1 Incretin Triagonist

October 17, 2024
·
6 min read
Press Releases

Acurx Pharmaceuticals Announces Participation at The Spartan Capital Investor Conference to Showcase Growth Companies and Foster High-Level Investor Engagement

October 17, 2024
·
3 min read
Press Releases

OmniaBio Announces Opening of New Commercial Manufacturing Facility in Canada, Bringing Life-Saving Cell and Gene Therapies to Patients

October 17, 2024
·
6 min read
News

Clarametyx Biosciences Announces Progress on Study of Antibody Therapy CMTX-101 for Infections Associated With Cystic Fibrosis

October 17, 2024
·
4 min read
Press Releases

Anavex Life Sciences Announces Encouraging Preliminary Biomarker Results from Ongoing Phase 2 Study of ANAVEX®3-71 for the Treatment of Schizophrenia

October 17, 2024
·
9 min read